Ten years of sorafenib in hepatocellular carcinoma: Are there any predictive and/or prognostic markers?

doi:10.3748/wjg.v24.i36.4152

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 24, Issue 36

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (11402)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-1) series, Tables (1-2) series.

Item

Count

PDF

1487

WORD

196

HTML

6786

Figures (1-1)

140

Tables (1-2)

131

Sum=8740

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

1036

Download

1626

Sum=2662

Sep 28, 2018 (publication date) through Apr 24, 2024

Times Cited of This Article

Times Cited (130)

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Minireviews

World J Gastroenterol. Sep 28, 2018; 24(36): 4152-4163
Published online Sep 28, 2018. doi: 10.3748/wjg.v24.i36.4152

Open in New Tab Full Size Figure Download Figure

Figure 1 Sorafenib pathaway and the main molecular factors. Ang: Angiopoietin; Tie2: Tyrosine-protein kinase receptor; PDGFR: Platelet-derived growth factor receptors; VEGFR: Vascular endothelial growth factor receptor; SCF: Stem cell factor; PI3K: PhosphatidylInositol 3-Kinase; Akt/PKB: Protein-chinasi B; eNOS: Endothelial nitric oxide synthase; NO: Nitric oxide; P: Phospho-; MEK: Mitogen-activated protein kinase kinase; ERK: Extracellular signal–regulated kinase.

Citation: Marisi G, Cucchetti A, Ulivi P, Canale M, Cabibbo G, Solaini L, Foschi FG, De Matteis S, Ercolani G, Valgiusti M, Frassineti GL, Scartozzi M, Casadei Gardini A. Ten years of sorafenib in hepatocellular carcinoma: Are there any predictive and/or prognostic markers? World J Gastroenterol 2018; 24(36): 4152-4163
URL: https://www.wjgnet.com/1007-9327/full/v24/i36/4152.htm
DOI: https://dx.doi.org/10.3748/wjg.v24.i36.4152